tm logo
NS NEUROSCIENCE
Live/Registered
REGISTERED

on 12 Dec 2017

Last Applicant/ Owned by

ATTN: BILL SEVOLD, CEO

OSCEOLA

WI

54020

Serial Number

87484979 filed on 12th Jun 2017

Registration Number

5355202 registered on 12th Dec 2017

in the Principal Register

Correspondent Address

DAVID GULBRANSEN

LAW OFFICE OF DAVID GULBRANSEN

159 N. MARION ST., SUITE 172

OAK PARK, IL 60301

Filing Basis

1. use application currently

Disclaimer

"NEUROSCIENCE"

NS NEUROSCIENCE

The mark consists of The letters "NS" inscribed in a trapezoid shape with rounded corners, featuring the literal "NeuroScience" below. Color is not claimed as a feature of the mark. Dietary and nutritional supplements that target a spectrum of neurotransmitter imbalances "NEUROSCIENCE"

Classification Information


Class [005]
Pharmaceutical Products


Dietary and nutritional supplements that target a spectrum of neurotransmitter imbalances


First Use Date in General

29th May 2002

First Use Date in Commerce

29th May 2002

Mark Details


Serial Number

No 87484979

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.13.02 -

Plain single or multiple line quadrilaterals

26.13.21 -

Quadrilaterals that are completely or partially shaded

Description of Design Search

The mark consists of The letters "NS" inscribed in a trapezoid shape with rounded corners, featuring the literal "NeuroScience" below.

Legal History


Show more

Status DateAction Taken
22nd Aug 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
12th Dec 2017REGISTERED-PRINCIPAL REGISTER
26th Sep 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26th Sep 2017PUBLISHED FOR OPPOSITION
06th Sep 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18th Aug 2017ASSIGNED TO LIE
07th Aug 2017APPROVED FOR PUB - PRINCIPAL REGISTER
11th Jul 2017TEAS/EMAIL CORRESPONDENCE ENTERED
10th Jul 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
10th Jul 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED